Serum OPN concentrations according to clinical/imaging data in the pooled cohort of patients with giant cell arteritis
| OPN concentrations (ng/mL) (mean±SD) | |||
| Presence | Absence | p | |
| Cranial symptoms | 104.78±59.60 | 118.56±75.16 | 0.491 |
| Systemic symptoms | 118.45±61.70 | 82.70±57.50 | 0.028 |
| Ischaemic symptoms | 79.91±57.90 | 117.29±61.32 | 0.028 |
| Strong SIR | 132.56±77.56 | 97.46±53.40 | 0.039 |
| PMR | 118.17±74.27 | 101.15±54.45 | 0.287 |
| LVV* | 109.44±61.88 | 115.55±69.45 | 0.799 |
| Aortic dilation† | 111.58±46.74 | 105.56±70.96 | 0.754 |
*Evaluated in 42 patients.
†Evaluated in 34 patients.
LVV, large vessel vasculitis; OPN, osteopontin; PMR, polymyalgia rheumatica; SIR, systemic inflammatory response.